https://www.selleckchem.com/pr....oducts/PHA-739358(Da
The main reason for not restarting or commencing ATT was concern about recurrent ICH (80.8%). National or international clinical guidelines would be advantageous to support decision-making (84.3%). Other helpful resources reported were multidisciplinary team involvement (46.9%) and patient education (82%). In summary, most survey respondents would prescribe OAC therapy for patients with AF who have sustained an ICH on OAC and would restart OAC 30 days post-ICH. The risk of recurrent ICH was the main reason for not pre
Like
Comment
Share
